MIT researchers have developed nanosized antibodies that home in on the meshwork of proteins surrounding cancer cells. This approach could be track tumors as they grow, metastasize or respond to treatment, or as a way to deliver cancer drugs.
Source: EurekaAlert, https://www.eurekalert.org